Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
GLYCOMIMETICS INC (GLYC)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
21 Sep 2023
Rock Edwin
Chief Medical Officer, Officer
GLYCOMIMETICS INC
(GLYC)
375,403
+21%
65,403
$1.38
$90,256.14
SELL
17 May 2023
Hahn Brian M.
SVP Finance, CFO, Officer
GLYCOMIMETICS INC
(GLYC)
53,143
-6%
3,700
$1.95
$7,215.00
BUY
21 Feb 2023
Invus Public Equities, L.P.
10% Owner
GLYCOMIMETICS INC
(GLYC)
8,489,064
+4%
400,000
$1.78
$712,255.00
BUY
15 Feb 2023
Invus Public Equities, L.P.
10% Owner
GLYCOMIMETICS INC
(GLYC)
8,089,064
+23%
1,515,266
$2.00
$3,027,928.50
BUY
9 Feb 2023
Invus Public Equities, L.P.
10% Owner
GLYCOMIMETICS INC
(GLYC)
6,573,798
+0%
11,451
$3.24
$37,123.00
SELL
25 Jan 2023
SANDELL SCOTT D
10% Owner
GLYCOMIMETICS INC
(GLYC)
2,730,334
-57%
3,652,016
$3.14
$11,484,514.00
SELL
5 Jan 2023
SANDELL SCOTT D
10% Owner
GLYCOMIMETICS INC
(GLYC)
4,737,613
-1%
71,362
$2.76
$196,859.22
SELL
30 Dec 2022
SANDELL SCOTT D
10% Owner
GLYCOMIMETICS INC
(GLYC)
4,776,836
-7%
398,133
$2.98
$1,185,885.80
BUY
22 Dec 2022
Rock Edwin
Chief Medical Officer, Officer
GLYCOMIMETICS INC
(GLYC)
310,000
+55%
110,000
$2.25
$247,500.00
BUY
17 Nov 2022
JUNIUS DANIEL M
Director
GLYCOMIMETICS INC
(GLYC)
63,250
+46%
20,000
$1.87
$37,400.00
BUY
14 Nov 2022
Rock Edwin
Chief Medical Officer, Officer
GLYCOMIMETICS INC
(GLYC)
200,000
+100%
200,000
$1.55
$309,000.00
BUY
11 Nov 2022
Girard Armand
SVP, Chief Business Officer, Officer
GLYCOMIMETICS INC
(GLYC)
29,161
+28%
6,500
$1.05
$6,825.00
BUY
11 Nov 2022
Semerjian Harout
Chief Executive Officer, Director, Officer
GLYCOMIMETICS INC
(GLYC)
25,000
+100%
25,000
$1.29
$32,250.00
BUY
11 Nov 2022
Magnani John L.
SVP of Research, CSO, Officer
GLYCOMIMETICS INC
(GLYC)
366,078
+14%
45,045
$1.17
$52,702.65
BUY
11 Nov 2022
PEARSON TIMOTHY R
Director
GLYCOMIMETICS INC
(GLYC)
24,650
+369%
19,400
$1.29
$25,026.00
BUY
11 Nov 2022
Hahn Brian M.
SVP Finance, CFO, Officer
GLYCOMIMETICS INC
(GLYC)
56,843
+54%
20,000
$1.06
$21,200.00
SELL
9 Mar 2022
Girard Armand
SVP, Chief Business Officer, Officer
GLYCOMIMETICS INC
(GLYC)
22,661
-9%
2,339
$1.09
$2,549.51
SELL
9 Mar 2022
Magnani John L.
SVP of Research, CSO, Officer
GLYCOMIMETICS INC
(GLYC)
321,033
-0%
3,227
$1.09
$3,517.43
SELL
9 Mar 2022
Hahn Brian M.
SVP Finance, CFO, Officer
GLYCOMIMETICS INC
(GLYC)
36,843
-7%
2,917
$1.09
$3,179.53
BUY
16 Nov 2021
Andrews Patricia S
Director
GLYCOMIMETICS INC
(GLYC)
45,250
+761%
40,000
$2.05
$82,000.00
SELL
28 Dec 2020
King Rachel K.
President, CEO, Director, Officer
GLYCOMIMETICS INC
(GLYC)
356,064
-19%
84,176
$3.91
$329,128.16
BUY
4 Nov 2020
BVF PARTNERS L P/IL
10% Owner
GLYCOMIMETICS INC
(GLYC)
4,980,812
+34%
1,266,737
$2.60
$3,293,516.00
BUY
30 Oct 2020
BVF PARTNERS L P/IL
10% Owner
GLYCOMIMETICS INC
(GLYC)
4,306,320
+27%
932,612
$2.75
$2,564,683.00
BUY
9 Mar 2020
JUNIUS DANIEL M
Director
GLYCOMIMETICS INC
(GLYC)
38,000
+111%
20,000
$3.40
$68,000.00
BUY
5 Sep 2019
BVF PARTNERS L P/IL
10% Owner
GLYCOMIMETICS INC
(GLYC)
3,639,935
+84%
1,668,746
$3.18
$5,309,950.00
BUY
13 Aug 2019
JUNIUS DANIEL M
Director
GLYCOMIMETICS INC
(GLYC)
18,000
+125%
10,000
$3.18
$31,800.00
SELL
16 Oct 2018
Magnani John L.
SVP of Research, CSO, Director, Officer
GLYCOMIMETICS INC
(GLYC)
75,793
-24%
25,000
$14.01
$350,212.53
SELL
11 Jun 2018
Hahn Brian M.
CFO, Officer
GLYCOMIMETICS INC
(GLYC)
0
-100%
19,345
$18.04
$348,983.80
SELL
10 May 2018
BARRIS PETER J
10% Owner
GLYCOMIMETICS INC
(GLYC)
4,702,791
-0%
9,539
$17.81
$169,889.60
SELL
10 May 2018
SANDELL SCOTT D
10% Owner
GLYCOMIMETICS INC
(GLYC)
4,702,791
-0%
9,539
$17.81
$169,889.60
SELL
10 May 2018
BARRETT M JAMES
Director, 10% Owner
GLYCOMIMETICS INC
(GLYC)
4,702,791
-0%
9,539
$17.81
$169,889.60
SELL
10 May 2018
NEW ENTERPRISE ASSOCIATES 10 L P
10% Owner
GLYCOMIMETICS INC
(GLYC)
4,702,791
-0%
9,539
$17.81
$169,889.60
SELL
8 Dec 2017
Thackray Helen M.
SVP Clinical Development, CMO, Officer
GLYCOMIMETICS INC
(GLYC)
148,615
-1%
2,000
$15.01
$30,020.00
SELL
18 Sep 2017
Thackray Helen M.
SVP Clinical Development, CMO, Officer
GLYCOMIMETICS INC
(GLYC)
150,615
-1%
2,000
$13.00
$26,000.00
SELL
25 May 2017
Thackray Helen M.
SVP Clinical Development, CMO, Officer
GLYCOMIMETICS INC
(GLYC)
152,615
-1%
2,000
$15.57
$31,140.00
SELL
19 May 2017
Thackray Helen M.
SVP Clinical Development, CMO, Officer
GLYCOMIMETICS INC
(GLYC)
154,615
-1%
2,000
$12.14
$24,280.00
BUY
20 Dec 2016
JUNIUS DANIEL M
Director
GLYCOMIMETICS INC
(GLYC)
5,000
+100%
5,000
$6.01
$30,050.00
SELL
3 Oct 2016
Thackray Helen M.
VP Clinical Development, CMO, Officer
GLYCOMIMETICS INC
(GLYC)
156,715
-2%
4,000
$7.00
$28,001.00
SELL
20 Jul 2016
Thackray Helen M.
VP Clinical Development, CMO, Officer
GLYCOMIMETICS INC
(GLYC)
160,615
-1%
2,000
$8.00
$16,000.00
SELL
1 Jul 2016
Thackray Helen M.
VP Clinical Development, CMO, Officer
GLYCOMIMETICS INC
(GLYC)
162,615
-11%
22,000
$7.00
$153,953.84
BUY
4 Mar 2016
Goldberg Mark Alan
Director
GLYCOMIMETICS INC
(GLYC)
11,497
+945%
10,397
$4.77
$49,630.08
Home